Skip to main content
. Author manuscript; available in PMC: 2014 Oct 4.
Published in final edited form as: J Proteome Res. 2013 Aug 28;12(10):10.1021/pr400549e. doi: 10.1021/pr400549e

Figure 2.

Figure 2

Electropherograms of the N-glycans derived from blood serum samples from (a) a control individual and (b)–(c) ovarian cancer patients prior to (pre-treatment) and after (post-treatment) an experimental drug treatment. N-Glycan peaks with migration times from 55 to 100 s were used for the disease-state analysis, and the labeled peaks contributed significantly to the differentiation of sample groups. Peak numbers were assigned relative to the peak areas from a reference electropherogram from a pre-treatment sample. Separation performance was evaluated with peaks at 62.1, 72.2, 76.3, and 87.0 s. The separation channel was 22 cm long and was operated at 1250 V/cm.